-
Swiss probe Google dropping search choice on Android phones
-
France and Spain clash in World Cup semi-final
-
MEXC Reports 7.1 Billion USDT in SpaceX Futures Volume as Q2 Closes the Gap to Wall Street
-
Knight wants England women to play more red-ball cricket after India loss
-
DR Congo health workers on Ebola front line threaten strike
-
Oil extends gains after fresh US strikes
-
Turn off addictive features on social media for children, say EU lawmakers
-
EU population to peak in 2029 before long-term decline
-
Bumrah returns for India as England bat in 1st ODI
-
Fire ravages historic forest outside Paris
-
US strikes Iran, vows to reimpose naval blockade
-
57 gored or bruised during Spain's San Fermin bull runs
-
Oil extends gains after fresh US strikes, stocks mostly rise
-
Wildfires advance in forest south of Paris
-
Families claim bodies as Bangkok fire toll rises to 30
-
Ukrainian men in Poland face legal limbo
-
Egg-free school meals scramble politics in India
-
Wildlife rescuers help birds survive Pakistan's hotter summers
-
US strikes Iran for third day, will reimpose blockade
-
Messi meets England at last with World Cup final place on the line
-
Italy's Cannone gets four-match ban for red card against All Blacks
-
Oil extends gains after latest US strikes, tech suffers more losses
-
Co-star says Sam Neill battled pneumonia before death
-
Young Australian men falling victim to online sexual extortion: regulator
-
Armenian apricots become geopolitical battleground with Russia
-
New era for Gibraltar as border controls with Spain set to end
-
Jay-Z pays tribute to NY hometown crowd and his 30-year legacy
-
England face might of Messi's Argentina in World Cup semi-final
-
Birthday boy Yamal stands by 'no fear' comment ahead of France clash
-
Spain to go on 'front foot' against France in World Cup semi: De la Fuente
-
Bridgeline Wins Competitive AI Search Deal with Leading Distribution Company
-
Medical Care Technologies Inc. (OTC PINK:MDCE) Snapshot Recipes AI Powered Mobile App Hits New Milestone with Freemium Model and Strong Marketing Results
-
Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant
-
ReElement Technologies Announces $25 Million Department of War Investment to Expand U.S. Critical Mineral Refining Capacity
-
Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
-
Kaney Announces $2.88 Million Investment to Expand BGT Aerospace Operations in Freeland
-
Valantor Acquires EyeLevel and Launches Enterprise Visual Intelligence Platform
-
Cytta Air Releases Demonstration Video Showcasing American-Built Prototype Platforms and Proprietary Command-and-Control Technology
-
First Canadian Graphite Appoints Tony La Mantia to Advisory Board
-
ESGold Executes Definitive Agreement to Acquire Strategic Montauban Claims
-
Eagle Plains and Pacific Bay Minerals Execute Option Agreement for Haskins Critical Minerals Project, British Columbia
-
Prospect Ridge Aims For Discovery: Drilling Begins At The Excalibur Copper-Gold Porphyry Target
-
Abasca Increases Loki Flake Graphite Resource and Confirms Second Mineralized Trend at Thor Zone
-
U.S. Polo Assn. Returns to 2026 DMMI Royal Charity Polo Cup as Official Apparel and Team Sponsor
-
INEO Provides Preliminary Q4 Revenue and Order Backlog Update
-
Silver Spruce Resources, Inc. Purchases 100% Interest in Pino de Plata Claims in Mexico
-
Well Done Foundation and Zefiro Methane Corp. Announce Teaming Agreement to Expand Orphan Well Plugging Nationwide
-
Instawork Announces 2026 Flexible Work Award Winners
-
FireFox Gold Expands Drill Program at Mustajärvi and Commences Drilling at the Sarvi Project in Lapland, Finland
-
Agronomics Limited Announces Director/PDMR Shareholding
Turkish doctor on 'terror' trial over chemical arms comment
The head of the Turkish Doctors' Union went on trial Friday on "terror" charges linked to her calls for a probe into the army's alleged use of chemical weapons against Kurdish fighters in Iraq.
Sebnem Korur Fincanci was arrested and jailed on October 26 after becoming one of the most prominent public figures to draw attention to reports that first surfaced in media outlets close to the outlawed Kurdistan Workers' Party (PKK).
The PKK has been waging a bloody insurgency against the Turkish state since the 1980s that has seen it listed as a terrorist organisation by Ankara and its Western allies.
The Turkish government has firmly rejected the allegations and President Recep Tayyip Erdogan has accused Fincanci of "speaking the language of terrorism".
Fincanci has been charged with disseminating "terror propaganda" -- a crime that has seen past defendants sentenced to 13 years in jail.
Her initial detention sparked street protests in Istanbul that ended with dozens of arrests.
The 63-year-old forensic medicine expert entered the packed Istanbul courtroom holding a defiant fist in the air while her supporters applauded and dozens of anti-riot police looked on.
Fincanci once again called for "an effective investigation" including on-the-ground inspections and autopsies of the Kurdish fighters.
"As a human rights defender, I have a responsibility to defend freedom of expression and the public's right to information," she told the court.
The PKK said 17 of its fighters had died in chemical weapons attacks in the mountains and caves of northern Iraq.
Fincanci is known in Turkey as both a forensics expert and a human rights campaigner who openly speaks out against Erdogan's government.
Amnesty International and Human Rights Watch issued a joint call with five other organisations for Fincanci's release pending trial.
"Korur Fincanci is a distinguished expert on the documentation of torture," they said in a joint statement.
"Her work should be lauded, not punished," the World Medical Association's German chairman Frank Ulrich Montgomery said in the statement.
But the chief prosecutor argued in court Friday that Fincanci "actively participated in propaganda activities of the PKK" and asked for her to remain in custody pending trial.
R.Chavez--AT